Form 4: Aethlon Medical Director Forfeits Shares for Tax

Aethlon Medical Director Chetan Shah forfeited 179 shares of common stock to cover tax withholdings related to restricted stock unit conversion.

Summary

• Chetan Shah, a Director of AETHLON MEDICAL INC (AEMD), reported a transaction on December 31, 2025.
• The transaction involved the forfeiture of 179 shares of common stock at a price of $2.77 per share.
• This forfeiture was executed to cover tax withholdings associated with the conversion of 268 vested and outstanding restricted stock units into common stock.
• The restricted stock units were part of a grant previously reported on April 25, 2025.
• Following this transaction, Chetan Shah directly beneficially owns 2,356 shares of Aethlon Medical common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary insider transaction for tax withholding purposes, which is neutral in sentiment regarding the company's operational or financial performance.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

This is a routine insider transaction for tax purposes, common across all industries when restricted stock units or other equity awards vest and convert into shares, requiring tax obligations to be met.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary transaction by a director to cover tax obligations, not indicative of a change in investment sentiment or company fundamentals.

Key Dates

Keywords

Aethlon Medical, AEMD, Chetan Shah, Form 4, Insider Transaction, Stock Forfeiture, Restricted Stock Units, Tax Withholding, Director